Varian Launches Solion PV Ion Implant Technology Platform in China at SNEC PV Power Expo 2011 Exhibition in Shanghai
February 23 2011 - 9:00AM
Marketwired
Varian Semiconductor Equipment Associates, Inc. ("Varian") (NASDAQ:
VSEA) today formally launched its Solion™ photovoltaic ("PV") ion
implant platform into the Chinese market at the SNEC PV Power Expo
2011.
Varian said it has partnered with several leading Chinese PV
manufacturers to insert Solion patterned ion implantation into
volume manufacturing by mid-year. Varian has established
engagements with over seven Chinese PV manufacturers who see
Solion's potential for accelerating their drive to grid parity by
delivering the precision and control required for high efficiency
cells while simplifying the manufacturing process to reduce the
overall cost per watt.
Solion enables solar module manufacturers to achieve a
combination of increased cell efficiency at lower production cost
by replacing traditional diffusion doping processes with ion
implant. In addition to greater precision and process control for
improved junction quality, this approach eliminates multiple
production steps, improves cell uniformity, and enables
significantly tighter binning.
Early Solion users have already adopted the enabling patterned
implant technology to produce crystalline solar cells in volume
with conversion efficiencies over 19 percent. Patterned
implantation provides a clear roadmap to efficiencies of 22 percent
at reduced cost per watt.
"The strong market interest in Solion from so many Chinese PV
manufacturers further validates the value of implant for
manufacturing high efficiency, low cost solar cells," said Varian's
Chief Executive Officer Gary Dickerson. "We are very excited to be
partnered with some of the market leaders in the fastest growing
region for production of solar cells. The combination of local
manufacturing expertise with Varian's technology leadership and
world class support will enable the PV industry to take a huge step
forward towards achieving grid parity."
Solion draws on Varian's 35-year history of leadership in ion
implant for the semiconductor industry, including the industry
standard Varian VIISta® product line, which has over 1,200 units in
the field. However, Solion is a completely new platform that
reflects the needs and priorities of PV module producers, including
the innovative ability to perform patterning and doping in a single
step using proprietary Precision Patterned Implant (PPI™)
technology.
Solion customers also benefit from Varian's highly regarded
worldwide service organization, having won the coveted VLSI
Research Award for 13 of the last 14 years.
Varian will be exhibiting at SNEC PV Power Expo in Shanghai from
February 22 - 24, at booth number 215 in Hall number 5.
About Varian Semiconductor Equipment
Associates, Inc.
Varian is a leading supplier of ion implantation equipment used
in the fabrication of semiconductor chips and photovoltaic modules.
Varian's products are used by manufacturers worldwide to produce
high-performance semiconductor devices and solar panels. Customers
have made Varian the market leader in ion implant because of its
architecturally superior products that lower their costs and
improve their productivity.
Varian provides support, training, and after-market products and
services that help its customers to obtain high utilization and
productivity, reduce operating costs, and extend capital
productivity of customer investments through multiple product
generations. Varian has ranked #1 in the VLSI Research Customer
Satisfaction Survey 13 times over the last 14 years. Varian
operates globally and is headquartered in Gloucester,
Massachusetts. More information can be found on Varian's web site
at www.vsea.com
Safe Harbor This press release contains
forward-looking statements for purposes of the safe harbor
provisions under The Private Securities Litigation Reform Act of
1995. For this purpose, statements concerning the expected
installation base of Varian's Solion implant product in the Chinese
market, the expected technical and commercial advantages offered by
the Solion implant product to PV cell manufacturers and any
statements using the terms "believes," "anticipates," "will,"
"expects," "plans" or similar expressions, are forward-looking
statements. The forward-looking statements involve a number of
risks and uncertainties. Among the important factors that could
cause actual results to differ materially from those indicated by
such forward-looking statements are: volatility in the
semiconductor and solar equipment industries; intense competition
in the semiconductor and solar equipment industries; Varian's
dependence on a small number of customers; fluctuations in Varian's
quarterly operating results; market adoption of Varian's new
products, such as the Solion implant product; Varian's exposure to
risks of operating internationally; uncertain protection of
Varian's patent and other proprietary rights; Varian's reliance on
a limited group of suppliers; Varian's ability to manage potential
growth, decline and strategic transactions; Varian's reliance on
one primary manufacturing facility; and Varian's dependence on
certain key personnel. These and other important risk factors that
may affect actual results are discussed in detail under the caption
"Risk Factors" in Varian's Annual Report on Form 10-K for the
fiscal year ended October 1, 2010 and in other reports filed by
Varian with the Securities and Exchange Commission. Varian cannot
guarantee any future results, levels of activity, performance or
achievement. Varian undertakes no obligation to update any of the
forward-looking statements after the date of this release.
Contacts: Bob Halliday Executive Vice President Chief
Financial Officer 978.282.7597 Tom Baker Vice President, Finance
978.282.2301
Varian (NASDAQ:VSEA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Varian (NASDAQ:VSEA)
Historical Stock Chart
From Jul 2023 to Jul 2024